LexDanaLexDanabeta
Inventor

CHIEN HUANG LIN

Inventor
TW

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07CAcyclic or carbocyclic compounds25%
PatentTitleYear
12,453,708Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases202511,833,122Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases202311,278,523Indoline derivatives for treatment and/or prevention of fibrosis diseases2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to UNIV TAIPEI MEDICAL (1)· patent assignee history
2022–2025Based in TW· patent location history
2023–2025Patents assigned to CALGENT BIOTECHNOLOGY CO LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CALGENT BIOTECHNOLOGY CO LTD22023–2025
UNIV TAIPEI MEDICAL12022
Locations
LocationPatentsSpan
TW32022–2025